On Friday, Elevance Health Inc (NYSE: ELV) opened higher 3.71% from the last session, before settling in for the closing price of $283.48. Price fluctuations for ELV have ranged from $273.71 to $567.26 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 6.81%. Company’s average yearly earnings per share was noted -8.40% at the time writing. With a float of $224.79 million, this company’s outstanding shares have now reached $224.84 million.
Let’s determine the extent of company efficiency that accounts for 104200 employees. In terms of profitability, gross margin is 100.0%, operating margin of 3.73%, and the pretax margin is 3.73%.
Elevance Health Inc (ELV) Insider Activity
A key investor’s attitude towards the stock of the Healthcare Plans industry is another important factor to consider. The insider ownership of Elevance Health Inc is 0.17%, while institutional ownership is 93.52%. The most recent insider transaction that took place on Jul 18 ’25, was worth 2,438,951. In this transaction President and CEO of this company bought 8,500 shares at a rate of $286.94, taking the stock ownership to the 151,020 shares. Before that another transaction happened on Apr 24 ’25, when Company’s EVP & CFO sold 4,588 for $424.82, making the entire transaction worth $1,949,074. This insider now owns 18,977 shares in total.
Elevance Health Inc (ELV) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted 8.37 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at 9.65) by -1.28. Wall Street market experts anticipate that the next fiscal year will bring earnings of 4.1 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -8.40% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 4.41% during the next five years compared to 6.81% growth over the previous five years of trading.
Elevance Health Inc (NYSE: ELV) Trading Performance Indicators
Check out the current performance indicators for Elevance Health Inc (ELV). In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.35. Likewise, its price to free cash flow for the trailing twelve months is 12.40.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 23.49, a number that is poised to hit 5.47 in the next quarter and is forecasted to reach 32.19 in one year’s time.
Technical Analysis of Elevance Health Inc (ELV)
Looking closely at Elevance Health Inc (NYSE: ELV), its last 5-days average volume was 2.51 million, which is a jump from its year-to-date volume of 1.96 million. As of the previous 9 days, the stock’s Stochastic %D was 50.63%.
During the past 100 days, Elevance Health Inc’s (ELV) raw stochastic average was set at 10.96%, which indicates a significant decrease from 88.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 10.31 in the past 14 days, which was lower than the 11.72 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $341.02, while its 200-day Moving Average is $388.22. However, in the short run, Elevance Health Inc’s stock first resistance to watch stands at $298.21. Second resistance stands at $302.42. The third major resistance level sits at $309.67. If the price goes on to break the first support level at $286.75, it is likely to go to the next support level at $279.50. Should the price break the second support level, the third support level stands at $275.29.
Elevance Health Inc (NYSE: ELV) Key Stats
There are currently 225,178K shares outstanding in the company with a market cap of 66.20 billion. Presently, the company’s annual sales total 177,011 M according to its annual income of 5,980 M. Last quarter, the company’s sales amounted to 49,776 M and its income totaled 1,743 M.
